Greenblatt, David J.

Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone

Ciraulo, D. A., Barnhill, J. G., Ciraulo, A. M., Sarid‐Segal, O., Knapp, C., Greenblatt, D. J., & Shader, R. I. (1997) · The Journal of Clinical Pharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 28

Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys

Friedman, H., Redmond, D. E., & Greenblatt, D. J. (1991) · Psychopharmacology

Pharmacogenetics and Drug MetabolismForensic Toxicology and Drug Analysis

Cited by 24

Imipramine and Buspirone in Patients With Panic Disorder Who Are Discontinuing Long-term Benzodiazepine Therapy

Rynn, M., García-España, F., Greenblatt, D. J., Mandos, L. A., Schweizer, E., & Rickels, K. (2003) · Journal of Clinical Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCardiac Health and Mental Health

Cited by 23

Chronic benzodiazepine administration

Galpern, W. R., Miller, L. G., greenblatt, D. J., Szabo, G. K., Browne, T. R., & Shader, R. I. (1991) · Biochemical Pharmacology

Neuroscience and Neuropharmacology ResearchEpilepsy research and treatment

Cited by 17